Abstracts must be submitted online in English through the submission system.

Each abstract will receive a unique submission number; please use this in all correspondence.

Abstracts can be edited until the submission deadline but should not be resubmitted.

Only one submission per abstract is allowed. Abstracts submitted to multiple categories will be automatically rejected without review.

Abstracts accepted for presentation require the presenting author to attend the congress.

Abstracts must contain original material that has not been previously published or accepted for publication.

Abstracts must not have been previously presented at an international meeting or submitted to another congress with a concurrent review process.

Failure to disclose prior publication or presentation will result in the senior author being disqualified from submitting abstracts to EUPSA for the following two years.

Authorship and content cannot be altered after acceptance. Abstract titles, authors, and affiliations will be published as submitted.

A senior author or co-author is expected to attend if the presenting author is a trainee. Should unforeseen circumstances preclude this from occurring, another co-author of the abstract from the trainee’s institution should replace. The senior author is obliged if required to participate in the discussion following the trainee’s presentation.

Evidence of ethical approval must be included for studies involving humans or animals (exceptions may apply for retrospective studies, following institutional rules).

File type: MS Word (.doc/.docx)

Font: Calibri, 10 pt

Title: ALL CAPITALS

Length: maximum 250 words (including figures/tables, fitting on one A4 page)

Structure:

• Original abstracts: Aim, Methods, Results, Conclusions
• Case reports: Aim, Case description, Conclusions

One figure or table may be included.

Abstracts must include clear description of results with data; reporting only p-values is insufficient.

Abstracts exceeding the word or page limits will not be accepted.

First-time users must create a log-in profile to the submission system; the same email/password can be used for multiple submissions.

Each abstract must be submitted in one category only. Case reports may be submitted only in the case report category.

All double submissions (e.g., altering the title or resubmitting to multiple categories) will be automatically rejected.

Reviews are blinded: author names and/or institutions must not appear in the abstract text or title.

If you want to withdraw an abstract, please contact the EUPSA Scientific office chairperson.

Authors will be notified of abstract acceptance/rejection by email. The submitting author is responsible for updating any changes in email address.

Scale 1 to 5 or reject; 1 = extremely poor to 5 = extremely good). Total score range: 4–20.

Originality

Methodology

Results (quality and presentation)

Relevance

Previously published, accepted, or presented abstracts (as above)

Submission to another congress with parallel review process

Exceeding abstract length limits

Identifying information in title/text

Submission of same abstract to multiple abstract categories

Authors of abstracts accepted for oral or poster presentation at EUPSA 2027 are invited to submit a manuscript to the official congress journal.

Manuscript submission will open after the congress and remain open for one month. Further details, including submission dates and deadlines, will be announced in due course.